Literature DB >> 1087055

On the characterization of acquired inhibitors to ristocetin induced platelet aggregation found in patients with von Willebrand's disease.

N Egberg, M Blombäck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1087055     DOI： 10.1016/0049-3848(76)90209-7

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  5 in total

1.  Interaction of platelet membrane receptors with von Willebrand factor, ristocetin, and the Fc region of immunoglobulin G.

Authors:  A Moore; G D Ross; R L Nachman
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

Review 2.  Immunologically generated circulating anticoagulants in humans.

Authors:  R L Edwards; C J Wakem
Journal:  Surv Immunol Res       Date:  1984

Review 3.  Alloantibodies in von Willebrand disease.

Authors:  Paula D James; David Lillicrap; Pier M Mannucci
Journal:  Blood       Date:  2013-01-07       Impact factor: 22.113

4.  Nonsense mutations of the von Willebrand factor gene in patients with von Willebrand disease type III and type I.

Authors:  Z P Zhang; M Lindstedt; G Falk; M Blombäck; N Egberg; M Anvret
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

5.  Monitoring of von Willebrand factor inhibitors in patients with type 3 von Willebrand disease using a quantitative assay.

Authors:  Connie H Miller
Journal:  Haemophilia       Date:  2021-06-05       Impact factor: 4.263
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.